HYPER-IGA IS ASSOCIATED WITH HIGHER MORTALITY AND WORSE LIVER-RELATED OUTCOMES IN PATIENTS WITH MASLD-MASH: A MULTINATIONAL ANALYSIS

Authors

Do Han Kim MD, Department of Medicine, Mount Sinai Morningside and West, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Donghyun Ko MD, Department of Internal Medicine, Bridgeport Hospital, Yale New Haven Health, Bridgeport, CT, USA.Follow
Wilhelm S. Basegoda MD, University of South Alabama, Mobile, AL, USA
Luis M. Nieto MD, Division of Gastroenterology and Hepatology, Emory University, Atlanta, GA, USA.
Pedro Palacios Argueta MD, Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, Philadelphia, PA, USA
Paul T. Kroner MD, Department of Gastroenterology, Riverside Health System, Newport News, VA, USA.
Frank J. Lukens MD, Division of Gastroenterology and Hepatology, Mayo Clinic Florida, Jacksonville, FL, USA

Document Type

Conference Proceeding

Abstract

The aim of this study is to determine whether hyper-IgA increases the risk of liver-related outcomes in patients with MASLD/MASH

Publication Date

5-2025

Recommended Citation

Kim, Do Han MD; Ko, Donghyun MD; Basegoda, Wilhelm S. MD; Nieto, Luis M. MD; Palacios Argueta, Pedro MD; Kroner, Paul T. MD; and Lukens, Frank J. MD, "HYPER-IGA IS ASSOCIATED WITH HIGHER MORTALITY AND WORSE LIVER-RELATED OUTCOMES IN PATIENTS WITH MASLD-MASH: A MULTINATIONAL ANALYSIS" (2025). Posters. 90.
https://scholar.bridgeporthospital.org/poster_presentations/90